Could weight-loss medications such as Ozempic and Wegovy offer benefits beyond weight reduction? Recent research indicates that these GLP-1 therapies might provide heart protection following a heart attack. Scientists discovered that these medications can enhance circulation in the heart's minute vessels, which is crucial since many individuals who experience heart attacks encounter a concealed risk known as 'no-reflow.' Even with the main artery reopened, smaller vessels may remain constricted, leading to permanent harm and a heightened risk of heart failure. However, GLP-1 medications could prevent this issue by relaxing the small cells that constrict capillaries during a heart attack. This permits blood to flow to the injured regions and aids in the heart's recovery. This finding has the potential to revolutionize the way heart attacks are managed, as a drug currently utilized by millions may also serve as a life-saving asset.
